| 注册
首页|期刊导航|新医学|基于肠道菌群机制的1型糖尿病防治研究

基于肠道菌群机制的1型糖尿病防治研究

李莹 徐平 薛萌 梁真 王嘉森

新医学2025,Vol.56Issue(4):414-419,6.
新医学2025,Vol.56Issue(4):414-419,6.DOI:10.12464/j.issn.0253-9802.2023-0372

基于肠道菌群机制的1型糖尿病防治研究

Research on the prevention and treatment of type 1 diabetes based on the mechanism of gut microbiota

李莹 1徐平 1薛萌 1梁真 1王嘉森1

作者信息

  • 1. 暨南大学第二临床医学院,广东 深圳 518020
  • 折叠

摘要

Abstract

The incidence of type 1 diabetes mellitus(T1DM)is increasing globally,with environmental factors playing a significant role in its onset and progression.Studies have shown that gut microbiota dysbiosis may lead to T1DM through mechanisms such as altering intestinal permeability,modifying the abundance of microbial metabolites,and regulating immune responses.While insulin remains the primary therapeutic means,targeting the gut microbiota has emerged as a promising research focus for T1DM intervention.This article reviews the relationship between gut microbiota and T1DM,discusses the preventive and therapeutic effects of probiotics on T1DM and their underlying mechanisms,aiming to provide new insights for T1DM prevention and treatment research.

关键词

1 型糖尿病/肠道菌群/益生菌/预防/治疗

Key words

Type 1 diabetes mellitus/Gut microbiota/Probiotics/Prevention/Treatment

引用本文复制引用

李莹,徐平,薛萌,梁真,王嘉森..基于肠道菌群机制的1型糖尿病防治研究[J].新医学,2025,56(4):414-419,6.

基金项目

国家自然科学基金(82170842) (82170842)

深圳市科技计划项目(KCXFZ20201221173600001) (KCXFZ20201221173600001)

新医学

0253-9802

访问量2
|
下载量0
段落导航相关论文